title: Mutation and expression of the p53 gene during chemical hepatocarcinogenesis in F344 rats.
abstract: Inactivation of the p53 gene is one of the most frequent genetic alterations in carcinogenesis. We studied gene mutations, the mRNA expression of p53, and the accumulation of p53 protein in chemical hepatocarcinogenesis in rats. Samples consisting of 44 precancerous foci and 18 cancerous foci were collected by laser capture microdissection (LCM), and analyzed for mutations in rat p53 gene exons 5-8 by PCR-single-strand conformational polymorphism (PCR-SSCP). We found that 25 PCR-SSCP bands of exons 6/7 and 8 were altered in 22/62 (35.4%) LCM samples. Direct p53 gene sequencing showed that 20/62 (9 precancer, 11 cancer) (32.3%) LCM samples exhibited 34 point mutations. Ten LCM samples exhibited double or triple mutations in exons 6/7 and 8 simultaneously. A quantitative analysis of p53 mRNA showed that p53 mRNA peaked at an early stage (week 6) in the precancerous lesion, 20 times that of adjacent normal tissue, and returned to normal by week 23. Similar to precancer, p53 mRNA in cancer was five times as high as that of adjacent normal tissue at week 12, and was closer to normal at week 23. When p53 mRNA declined from a high to low, positive immunostaining for the p53 protein began to be seen in precancerous and cancerous foci, suggesting that the p53 protein had accumulated in these foci. Results show that p53 gene mutation is present in initial chemical hepatocarcinogenesis and p53 mRNA concentration is clearly elevated before gene mutation. Once the p53 gene has mutated, mRNA concentration progressively declines, suggesting that mutation leads to inactivation of the p53 gene.
authors.affiliation: Department of Biochemistry, Akita University School of Medicine, 1-1-1 Hondo, 010-8543, Akita, Japan.
authors.forename: Yan
authors.initials: Y
authors.lastname: Fu
authors.forename: Weiguo
authors.initials: W
authors.lastname: Deng
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Kawarada
authors.forename: Masami
authors.initials: M
authors.lastname: Kawagoe
authors.forename: Ying Zhe
authors.initials: YZ
authors.lastname: Ma
authors.forename: Xinghua
authors.initials: X
authors.lastname: Li
authors.forename: Naxin
authors.initials: N
authors.lastname: Guo
authors.forename: Takashi
authors.initials: T
authors.lastname: Kameda
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Terada
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Sugiyama
mesh_terms: D000818:Animals; D001483:Base Sequence; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D005091:Exons; D016158:Genes, p53; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000139:chemically induced*; D008297:Male; D008957:Models, Genetic; D008969:Molecular Sequence Data; D009154:Mutation; D017354:Point Mutation; D018807:Polymorphism, Single-Stranded Conformational; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis*
chemical_list: D012333:RNA, Messenger; D016159:Tumor Suppressor Protein p53